226 related articles for article (PubMed ID: 3311206)
1. A specific assay for anti-HLA antibodies: application to platelet donor selection.
Millard FE; Tani P; McMillan R
Blood; 1987 Nov; 70(5):1495-9. PubMed ID: 3311206
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
Heal JM; Blumberg N; Masel D
Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
[TBL] [Abstract][Full Text] [Related]
4. [Refractory effect and alloimmunization after transfusion of thrombocytes].
Volkova RI; Agranenko VA
Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
Fagundes IS; Franz JM; Jobim MS; Arend A; Merzoni J; Cardone JM; Gil B; Sekine L; Jobim LF
Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
[TBL] [Abstract][Full Text] [Related]
6. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
7. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
8. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
[TBL] [Abstract][Full Text] [Related]
9. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia.
Sayed D; Bakry R; El-Sharkawy N; Zahran A; Khalaf MR
J Clin Apher; 2011; 26(1):23-8. PubMed ID: 21312256
[TBL] [Abstract][Full Text] [Related]
11. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
[TBL] [Abstract][Full Text] [Related]
12. Posttransfusion purpura following bone marrow transplantation.
Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
[TBL] [Abstract][Full Text] [Related]
13. An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.
Marsh JC; Stanworth SJ; Pankhurst LA; Kallon D; Gilbertson AZ; Pigden C; Deary AJ; Mora AS; Brown J; Laing ES; Choo LL; Hodge R; Llewelyn CA; Harding K; Sage D; Mijovic A; Mufti GJ; Navarrete CV; Brown CJ
Blood; 2021 Jan; 137(3):310-322. PubMed ID: 33475737
[TBL] [Abstract][Full Text] [Related]
14. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
Friedberg RC; Donnelly SF; Mintz PD
Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
[TBL] [Abstract][Full Text] [Related]
16. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
[TBL] [Abstract][Full Text] [Related]
17. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
Kickler TS; Ness PM; Braine HG
Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
[TBL] [Abstract][Full Text] [Related]
18. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
Menitove JE; Duquesnoy RJ
Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
[TBL] [Abstract][Full Text] [Related]
19. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
Karlström C; Linjama T; Edgren G; Lauronen J; Wikman A; Höglund P
Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964
[TBL] [Abstract][Full Text] [Related]
20. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
Yam P; Petz LD; Scott EP; Santos S
Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]